The FDA reports include nausea, vomiting, diarrhea, abdominal pain, constipation, injection site reactions, and more severe outcomes including pancreatitis requiring hospitalization, gallbladder disease, severe hypoglycemia, and acute kidney injury
Retatrutide is an investigational medicinal product (IMP) accessible only through authorised clinical trials
So, how is your research diving into these effects and how to mitigate them
Among the substitute GLP-1 receptor agonists are: Albiglutide (Tanzeum) Exenatide (Bydureon, Byetta) Dulaglutide (Trulicity) Liraglutide (Saxenda, Victoza) These medications offer a range of options for individuals seeking alternatives to semaglutide, ensuring flexibility in obesity and diabetes management based on personal preferences and healthcare provider recommendations
Similarly, Mehdizadeh et al
You likely wont have too much of an appetite while you have diarrhea, so try to eat small amounts spread throughout the day